Dr. Ana Coroadinha

    Dr. Ana Sofia Coroadinha has a degree in Biochemistry (Faculdade de Ciências, Universidade de Lisboa). She performed her PhD in Gene Therapy in a tripartite felowship between Généthon (France), Helmholtz Centre for Infection Research (HZI) (Germany) and iBET (Portugal) (PhD degree granted in October 2005). From 2006 to 2008 she was an auxiliary researcher at iBET and ITQB-NOVA establishing a research group in animal cell molecular biotechnology, an area previously inexistent at the institute. Thus, three years later she became lab head (July 2009) of the Cell Line Development and Molecular Biotechnology Laboratory (iBET and ITQB-UNL). Dr. Ana Sofia Coroadinha’s research is focused on the development of virus-based biopharmaceuticals for vaccine and gene therapy purposes. It is supported on a multidisciplinary research bridging molecular biology, virology and cell biology. The purpose of her group is to elucidate virus-host cell interaction, develop novel molecular tools with the final aim of improving and developing novel therapeutics and prophylactics solutions for a better healthcare. She has over 40 papers published in reputed journals, has been serving as an editorial board member of reputed journals in the area of biotechnology and teaches in Master and PhD programs.